Viewing Study NCT03170960

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-05-20 @ 3:41 PM
Study NCT ID: NCT03170960
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-17
First Post: 2017-05-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor: Exelixis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Urothelial Carcinoma View
None Renal Cell Carcinoma View
None Non-Small Cell Lung Cancer View
None Castration-resistant Prostate Cancer View
None Triple Negative Breast Cancer View
None Ovarian Cancer View
None Endometrial Cancer View
None Hepatocellular Carcinoma View
None Gastric Cancer View
None Gastroesophageal Junction Adenocarcinoma View
None Colorectal Cancer View
None Head and Neck Cancer View
None Differentiated Thyroid Cancer View
None Lower Esophageal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Kidney View
None Bladder View
None Renal pelvis View
None Ureter View
None Urethra View
None Cancer View
None Prostate View
None Castration-resistant View
None Lung View
None Breast View
None Ovarian View
None Endometrial View
None Liver View
None Stomach View